Upendra Parvathaneni, M.B., FRANCR
Locations of Practice
1354 Aloha Street
Seattle, WA 98109
1570 N 115th Street
Seattle, WA 98133
1959 NE Pacific Street
Seattle, WA 98195
Dr. Parvathaneni is a radiation oncologist who specializes in the treatment of head and neck cancers. He is the University of Washington Department of Radiation Oncology program and disease site lead for head and neck cancers. Dr. Parvathaneni practices at UWMC, SCCA and SCCA Proton Therapy.
Patient Care Philosophy
“Treating patients as I would like to be treated if I were one.”
Education and Training
College: Annamalai University, India, 1990
Medical Education: Annamalai University, Rajah Muthaiah Medical College, India, 1993
Internship: Auckland Hospital, Internal Medicine, Auckland, New Zealand
- Palmerston North Hospital, Manawatu-Wanganui, New Zealand, 1999-2000
- Royal Australian & New Zealand College of Radiologists, Liverpool Hospital, New South Wales, Australia, 2000-2004
Advanced Fellowship: University of Texas, MD Anderson Cancer Center, Houston, TX, 2005-2006
Selected Publications from a Total of 70
Takagishi SR, Marx TE, Lewis CW, Shantha E, Juhlin ID, Blom A, Iyer JG, Liao JJ, Tseng YD, Fu T, Nghiem P, Parvathaneni U. Postoperative Radiation Therapy is associated with a Reduced Risk of Local Recurrence among Low Risk Merkel Cell Carcinomas of the Head & Neck. Advances in Radiation Oncology 2016, 1(4): 244-251. doi: 10.1016/j.adro.2016.10.003.
Gensheimer MF, Nyflot M, Laramore GE, Liao JJ, Parvathaneni U. Contribution of Submandibular gland and Swallowing structure Sparing to Post-Radiation therapy PEG dependence in Oropharynx cancer patients treated with split-neck IMRT technique. Radiation Oncology. 2016, Nov 15;11(1):151. doi: 10.1186/s13014-016-0726-3. PMID: 27846899
Bhatia S, Storer BE, Iyer JG, Moshiri A, Parvathaneni U, et al. Adjuvant Radiation therapy and Chemotherapy in Merkel Cell Carcinoma: Survival Analyses of 6,908 cases from the National Cancer Data Base. J Natl Cancer Inst. 2016 May 31;108(9). doi: 10.1093/jnci/djw042. PMID: 27245173
*Parvathaneni U, *Iyer J, Gooley T, et al. Single Fraction Radiation Therapy in Patients with Metastatic Merkel cell Carcinoma. Cancer Med. 2015 Aug;4(8):1161-70. DOI: http://dx.doi.org/10.1002/cam4.458. PMID: 25908228
Gensheimer MF, Liao JJ, Garden AS, Laramore GE and Parvathaneni U. Submandibular gland-sparing radiation therapy for locally advanced oropharyngeal squamous cancers: patterns of failure and xerostomia outcomes. Radiation Oncology 2014, Nov 26;9(1):255. doi:10.1186/s 13014-014-0255-x. PMID: 25424729
DL Berry, F Hong, B Halpenny, AH Partridge, JR Fann, S Wolpin, WB Lober, N Bush, U Parvathaneni, et al. The Electronic Self-Report Assessment for Cancer and Self-Care Support: Results of a Multi-Center Randomized Trial. J Clin Oncol. 32, 3:199-205, January 20, 2014. doi:10.1200/JCO.2013.48.6662. PMID: 24344222
Gensheimer MF, Rainey D, Douglas JD, Liao JJ, Laramore GE, Koh W, Parvathaneni U. Neutron Radiotherapy for Adenoid Cystic Carcinoma of the Lacrimal Gland. Ophthal Plast Reconstr Surg. 2013 Jul-Aug;29(4):256-60. doi:10.1097/IOP.0b013e318295f99b. PMID:23839633.
Johnson B, Sales LR, Winston A, Liao JJ, Laramore GE, Parvathaneni U. Fabrication of customized tongue-displacing stents: Considerations for use in patients receiving Head and Neck Radiotherapy. J Am Dent Assoc 2013 Jun;144(6):594-600. PMID:23729456.
RG Martins, U Parvathaneni, JE Bauman, et al. Cisplatin, radiation therapy with or without erlotinib in locally advanced squamous cell carcinoma of the head and neck: A randomized phase II trial. J Clin Oncol 31,11:1415-1421, April10, 2013. doi:10.1200/JCO.2012.46.3299. PMID:23460709.
Ang KK, Chen AY, Curran WJ, Garden AS, Harari PM, Murphy BA, Wong SJ, Bellm LA, Schwartz M, Newman J, Adkins D, Hayes DN, Parvathaneni U et al. Head and Neck Carcinoma in the United States: First Comprehensive Report of Longitudinal Oncology Registry of Head and Neck Carcinoma (LORHAN). Cancer. 2012 Dec 1;118(23):5783-92. doi:10.1002/cncr.27609. PMID:22569917.